CSPC Pharmaceutical Group Limited (1093.HK)

HKSE · Healthcare · Drug Manufacturers - General
7.92 HKD-4.58%As of 2026-11-22 · HKD
Last session low 7.86 HKDLast session high 8.23 HKD
52-week low 6.53 HKD52-week high 10.96 HKD
Market cap (USD)
$11.52B
Sector
Healthcare
P/E (TTM)
10.8x
Dividend yield
4.55%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in HKD.

IndicatorValueReading
RSI (14)40.6In the neutral range (30 to 70)
MACD (12, 26, 9)-0.19Above its signal line (-0.19); histogram 0.01
Bollinger %B (20, 2)26%Inside the bands (7.65 to 8.69)
SMA 208.17Price is 3.1% below
SMA 508.77Price is 9.7% below
SMA 2008.56Price is 7.5% below
ATR (20)4.55% of priceAverage true range per day
52-week position31%In the lower part of the 6.53 to 10.96 range

About CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.

Latest fiscal yearEnded 2025-12-31: revenue of 26.01B CNY and an operating margin of 16.1%.

More in Drug Manufacturers - General